Description
Operator of a molecular diagnostics company created to offer a microorganisms detecting platform. The company's platform offers a unique technology for rapid identification of all known infectious agents associated with human disease, enabling healthcare institutes to identify an unknown pathogen and appropriate treatment for a hospital patient with acute myelogenous leukaemia.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Out of Business | 01-Nov-2018 | 00000 | Completed | Out of Business | ||
2. Angel (individual) | 21-Sep-2016 | 00000 | 00000 | Completed | Startup | |
1. Accelerator/Incubator | Completed | Startup |